C-reactive Protein Concentration Is Associated With a Higher Risk of Mortality in a Rural Korean Population |
Lee, Jung Hyun
(Graduate School of Public Health, Yonsei University)
Yeom, Hyungseon (Department of Preventive Medicine, Yonsei University College of Medicine) Kim, Hyeon Chang (Department of Preventive Medicine, Yonsei University College of Medicine) Suh, Il (Department of Preventive Medicine, Yonsei University College of Medicine) Kim, Mi Kyung (Department of Preventive Medicine, Hanyang University College of Medicine) Shin, Min-Ho (Department of Preventive Medicine, Chonnam National University Medical School) Shin, Dong Hoon (Department of Preventive Medicine, Keimyung University School of Medicine) Koh, Sang-Baek (Department of Preventive Medicine, Yonsei University Wonju College of Medicine) Ahn, Song Vogue (Department of Preventive Medicine, Yonsei University Wonju College of Medicine) Lee, Tae-Yong (Department of Preventive Medicine, Chungnam National University School of Medicine) Ryu, So Yeon (Department of Preventive Medicine, Chosun University Medical School) Song, Jae-Sok (Department of Preventive Medicine and Institute of Catholic Kwandong University College of Medicine) Choe, Hong-Soon (Department of Preventive Medicine and Institute of Catholic Kwandong University College of Medicine) Lee, Young-Hoon (Department of Preventive Medicine and Institute of Wonkwang Medical Science, Wonkwang University School of Medicine) Choi, Bo Youl (Department of Preventive Medicine, Hanyang University College of Medicine) |
1 | Goyal A, Terry MB, Jin Z, Siegel AB. C-reactive protein and colorectal cancer mortality in U.S. adults. Cancer Epidemiol Biomarkers Prev 2014;23(8):1609-1618. DOI |
2 | Sung KC, Ryu S, Chang Y, Byrne CD, Kim SH. C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians. Eur Heart J 2014;35(27):1809-1816. DOI |
3 | Doran B, Zhu W, Muennig P. Gender differences in cardiovascular mortality by C-reactive protein level in the United States: evidence from the National Health and Nutrition Examination Survey III. Am Heart J 2013;166(1):45-51. DOI |
4 | Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004;109(21 Suppl 1):II2- II10. DOI |
5 | Windgassen EB, Funtowicz L, Lunsford TN, Harris LA, Mulvagh SL. C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians. Postgrad Med 2011;123(1):114-119. DOI |
6 | Li R, Hertzmark E, Louie M, Chen L, Spiegelman D. The SAS LGTPHCURV9 macro; 2011 [cited 2016 Sep 4]. Available from: https://cdn1.sph.harvard.edu/wp-content/uploads/sites/271/2012/09/lgtphcurv9_7-3-2011.pdf. |
7 | Iso H, Cui R, Date C, Kikuchi S, Tamakoshi A; JACC Study Group. C-reactive protein levels and risk of mortality from cardiovascular disease in Japanese: the JACC Study. Atherosclerosis 2009;207(1):291-297. DOI |
8 | Currie CJ, Poole CD, Conway P. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 2008;94(4): 457-462. DOI |
9 | Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107(3):499-511. DOI |
10 | Woloshin S, Schwartz LM. Distribution of C-reactive protein values in the United States. N Engl J Med 2005;352(15):1611-1613. |
11 | Saito I, Sato S, Nakamura M, Kokubo Y, Mannami T, Adachi H, et al. A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) study. Atherosclerosis 2007;194(1):238-244. DOI |
12 | Zhao Y, Wang R, Ma X, Yan X, Zhang Z, He X, et al. Distribution of C-reactive protein and its association with cardiovascular risk factors in a population-based sample of Chinese. Dis Markers 2010;28(6):333-342. DOI |
13 | Organization for Economic Cooperation and Development. Health status [cited 2015 Nov 29]. Available from: http://stats.oecd.org/index.aspx?DataSetCode=HEALTH_STAT. |
14 | Kuoppamaki M, Salminen M, Vahlberg T, Irjala K, Kivela SL, Raiha I. High sensitive C-reactive protein (hsCRP), cardiovascular events and mortality in the aged: a prospective 9-year follow-up study. Arch Gerontol Geriatr 2015;60(1):112-117. DOI |
15 | Smith KB, Humphreys JS, Wilson MG. Addressing the health disadvantage of rural populations: how does epidemiological evidence inform rural health policies and research? Aust J Rural Health 2008;16(2):56-66. DOI |
16 | Hage FG. C-reactive protein and hypertension. J Hum Hypertens 2014;28(7):410-415. DOI |
17 | Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009;373(9670):1175-1182. DOI |
18 | Lee EH, Park SK, Ko KP, Cho IS, Chang SH, Shin HR, et al. Cigarette smoking and mortality in the Korean Multi-center Cancer Cohort (KMCC) study. J Prev Med Public Health 2010;43(2): 151-158 (Korean). DOI |
19 | Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR, et al. Ethnic differences in C-reactive protein concentrations. Clin Chem 2008;54(6):1027-1037. DOI |
20 | Kim Y, Han BG; KoGES group. Cohort profile: the Korean genome and epidemiology study (KoGES) Consortium. Int J Epidemiol 2016. http://dx.doi.org/10.1093/ije/dyv316. |
21 | Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park) 2002;16(2):217-226. |
22 | World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment [cited 2016 Sep 4]. Available from: http://www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdf. |
23 | Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18(6):499-502. |
24 | Heinzl H, Kaider A. Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed 1997;54(3):201-208. DOI |
25 | Kim KI, Oh SW, Ahn S, Heo NJ, Kim S, Chin HJ, et al. CRP level and HDL cholesterol concentration jointly predict mortality in a Korean population. Am J Med 2012;125(8):787- 795.e4. DOI |
26 | Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 2007;65(12 Pt 2):S140-S146. DOI |
27 | Ding D, Wang M, Su D, Hong C, Li X, Yang Y, et al. Body mass index, high-sensitivity C-reactive protein and mortality in Chinese with coronary artery disease. PLoS One 2015;10(8): e0135713. DOI |
28 | Sung JW, Lee SH, Byrne CD, Chung PW, Won YS, Sung KC. High-sensitivity C-reactive protein is associated with the presence of coronary artery calcium in subjects with normal blood pressure but not in subjects with hypertension. Arch Med Res 2014;45(2):170-176. DOI |
29 | Kengne AP, Batty GD, Hamer M, Stamatakis E, Czernichow S. Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies. Diabetes Care 2012;35(2):396-403. DOI |
30 | Koenig W, Khuseyinova N, Baumert J, Meisinger C. Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998. Clin Chem 2008;54(2):335-342. DOI |
31 | Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104(23):2855-2864. DOI |
32 | Miranda JJ, Gilman RH, Smeeth L. Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart 2011;97(10):787-796. DOI |
33 | NACB LMPG Committee Members, Myers GL, Christenson RH, Cushman M, Ballantyne CM, Cooper GR, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem 2009;55(2):378-384. DOI |
34 | Makita S, Nakamura M, Satoh K, Tanaka F, Onoda T, Kawamura K, et al. Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. Atherosclerosis 2009;204(1):234-238. DOI |
35 | Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010;375(9709):132-140. DOI |
36 | Ridker PM. High-sensitivity C-reactive protein as a predictor of all-cause mortality: implications for research and patient care. Clin Chem 2008;54(2):234-237. DOI |
37 | Ahmadi-Abhari S, Luben RN, Wareham NJ, Khaw KT. Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study. Eur J Epidemiol 2013;28(7):541-550. DOI |